Trans-well migration assays performed on naïve SCLC cells revealed that FOXM1 inhibition with FDI-6 or NB-73 reduced the migratory capabilities of human SCLC cells (supplementary Fig. S4A-B). Here, FOXM1 is linked to small cell lung carcinoma.